Large-scale testing (Phase 3)UnknownNCT03780049What this trial is testingHAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-BWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 304
Testing effectiveness (Phase 2)Ended earlyNCT02958163What this trial is testingClinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)Who this might be right forLiver NeoplasmsHepatocellular Cancer Cliniques universitaires Saint-Luc- Université Catholique de Louvain 3
Early research (Phase 1)Study completedNCT02578602What this trial is testingMRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver CancerWho this might be right forAdult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more University of Southern California 26
Large-scale testing (Phase 3)Ended earlyNCT05171166What this trial is testingNeoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.Who this might be right forHepatocellular Carcinoma Peking University 18
Testing effectiveness (Phase 2)UnknownNCT04174781What this trial is testingAnti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCCWho this might be right forHepatocellular Carcinoma Zhejiang University 61
Large-scale testing (Phase 3)UnknownNCT04909866What this trial is testingThe Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label StudyWho this might be right forHepatocellular Carcinoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Not applicableNot Yet RecruitingNCT06971237What this trial is testingSIRT and Peri-immunotherapy : a New ConceptWho this might be right forAdvanced Hepatocellular Carcinoma (HCC), Classified as BCLC Stage B or C, Treated With a Combination of Selective Internal Radiation Therapy Assistance Publique - Hôpitaux de Paris 60
Not applicableUnknownNCT01470495What this trial is testingCombined Treatment of RFA and Sorafenib on Recurrent HCCWho this might be right forHCCRadiofrequency AblationSorafenib Southwest Hospital, China 430
Testing effectiveness (Phase 2)Looking for participantsNCT06607107What this trial is testingMFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan CriteriaWho this might be right forHepatocellular Carcinoma Non-resectable Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 29
Testing effectiveness (Phase 2)Ended earlyNCT05776875What this trial is testingAtezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCCWho this might be right forHepatocellular CarcinomaBCLC Stage B Hepatocellular Carcinoma Yale University 3
Not applicableStudy completedNCT07368530What this trial is testingUsing Machine Learning to Identify Responders to TACE or HAIC for uHCCWho this might be right forUnresectable Hepatocellular Carcinoma (HCC)BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma First Affiliated Hospital, Sun Yat-Sen University 3,000
Early research (Phase 1)Study completedNCT01666756What this trial is testingChinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerAdvanced Adult Hepatocellular Carcinoma+2 more City of Hope Medical Center 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04483284What this trial is testingStudy of TACE Combined With Camrelizumab in the Treatment of HCC PatientsWho this might be right forHepatocellular Carcinoma Shanghai Zhongshan Hospital 28
Large-scale testing (Phase 3)UnknownNCT03642561What this trial is testingEvaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACEWho this might be right forHepatocellular Carcinoma Fudan University 300
Testing effectiveness (Phase 2)Study completedNCT02940496What this trial is testingPembrolizumab (MK-3475) in Hepatocellular CarcinomaWho this might be right forBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatitis C Infection+8 more M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Ended earlyNCT05199285What this trial is testingA Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + BevacizumabWho this might be right forBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+8 more Academic and Community Cancer Research United 15
Testing effectiveness (Phase 2)Looking for participantsNCT07154082What this trial is testingApatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma (HCC) Wei Zhang 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05507632What this trial is testingDonafenib Plus Sintilimab in Combination With TACE in Patients With Unresectable Hepatocellular CarcinomaWho this might be right forUnresectable Hepatocellular Carcinoma Nanfang Hospital, Southern Medical University 48
Not applicableUnknownNCT02616926What this trial is testingHepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma First Affiliated Hospital, Sun Yat-Sen University 538
Testing effectiveness (Phase 2)WithdrawnNCT05327738What this trial is testingYttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular CarcinomaWho this might be right forBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+2 more OHSU Knight Cancer Institute